- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bioventix (BVXP)
Bioventix stock price live, this page displays LON BVXP stock exchange data. View the BVXP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bioventix real time stock price chart below.
What Is the Bioventix Stock Price Today?
The Bioventix stock price today is 1,570.0.
What Is the Stock Symbol for Bioventix?
The stock symbol for Bioventix is "BVXP."
What Stock Exchange Does Bioventix Trade On?
Bioventix is listed and trades on the London stock exchange.
Is Bioventix a Good Stock to Buy?
Determining whether Bioventix—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BVXP quote. (ISIN: GB00B4QVDF07)
What Is the Bioventix Stock Price Today?
The Bioventix stock price today is 1,570.0.
What Is the Stock Symbol for Bioventix?
The stock symbol for Bioventix is "BVXP."
What Stock Exchange Does Bioventix Trade On?
Bioventix is listed and trades on the London stock exchange.
Is Bioventix a Good Stock to Buy?
Determining whether Bioventix—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BVXP quote. (ISIN: GB00B4QVDF07)
1,570.0
-5.0(-0.32%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,570.0
1,570.0
52 wk Range
1,300.0
2,860.0
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,570.01,570.0
52 wk Range
1,300.02,860.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(9.55%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(9.55%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
BVXP Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Earnings
Latest Release
Mar 30, 2026
EPS / Forecast
0.68 / --
Revenue / Forecast
6.16M / --
Compare BVXP to Peers and Sector
Metrics to compare | BVXP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBVXPPeersSector | |
|---|---|---|---|---|
P/E Ratio | 11.1x | −3.4x | −0.4x | |
PEG Ratio | −2.16 | −0.01 | 0.00 | |
Price/Book | 7.5x | 2.7x | 2.6x | |
Price / LTM Sales | 6.6x | 5.3x | 3.1x | |
Upside (Analyst Target) | 147.6% | 116.3% | 51.8% | |
Fair Value Upside | Unlock | 1.6% | 7.5% | Unlock |
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. The company also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Bioventix (BVXP) Stock Price Today?
The Bioventix stock price today is 1,570.0 GBP.
What Stock Exchange Does Bioventix Trade On?
Bioventix is listed and trades on the London Stock Exchange.
What Is the Stock Symbol for Bioventix?
The stock symbol for Bioventix is "BVXP."
Does Bioventix Pay Dividends? What’s The Current Dividend Yield?
The Bioventix dividend yield is 9.55%.
What Is the Bioventix Market Cap?
As of today, Bioventix market cap is 82.03M GBP.
What Is Bioventix's Earnings Per Share (TTM)?
The Bioventix EPS (TTM) is 1.4.
When Is the Next Bioventix Earnings Date?
Bioventix will release its next earnings report on Mar 30, 2026.
From a Technical Analysis Perspective, Is BVXP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Bioventix Stock Split?
Bioventix has split 0 times.
How Many Employees Does Bioventix Have?
Bioventix has 12 employees.
What is the current trading status of Bioventix (BVXP)?
As of Jul 16, 2026, Bioventix (BVXP) is trading at a price of 1,570.0 GBP, with a previous close of 1,575.0 GBP. The stock has fluctuated within a day range of 1,570.0 GBP to 1,570.0 GBP, while its 52-week range spans from 1,300.0 GBP to 2,860.0 GBP.
What Is Bioventix (BVXP) Price Target According to Analysts?
The average 12-month price target for Bioventix is 3,900.0 GBP, with a high estimate of 3900 GBP and a low estimate of 3900 GBP. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +148.41% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.